🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
0.7904
+0.0423 (5.65%)
Nov 18, 2026, 12:45 PM EST - Market open

iBio, Inc. Statistics

Total Valuation

iBio, Inc. has a market cap or net worth of $50.83 million. The enterprise value is -$23.76 million.

Market Cap50.83M
Enterprise Value -23.76M

Important Dates

The last earnings date was Tuesday, November 10, 2026, after market close.

Earnings Date Nov 10, 2026
Ex-Dividend Date n/a

Share Statistics

iBio, Inc. has 64.31 million shares outstanding. The number of shares has increased by 496.26% in one year.

Current Share Class 64.31M
Shares Outstanding 64.31M
Shares Change (YoY) +496.26%
Shares Change (QoQ) +4.28%
Owned by Insiders (%) 1.32%
Owned by Institutions (%) 39.43%
Float 44.15M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 44.75
Forward PS n/a
PB Ratio 0.61
P/TBV Ratio 0.63
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.48, with a Debt / Equity ratio of 0.03.

Current Ratio 9.48
Quick Ratio 8.95
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1,711.84

Financial Efficiency

Return on equity (ROE) is -51.82% and return on invested capital (ROIC) is -29.05%.

Return on Equity (ROE) -51.82%
Return on Assets (ROA) -26.61%
Return on Invested Capital (ROIC) -29.05%
Return on Capital Employed (ROCE) -40.62%
Weighted Average Cost of Capital (WACC) 11.88%
Revenue Per Employee $46,739
Profits Per Employee -$1.52M
Employee Count23
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -27.31% in the last 52 weeks. The beta is 1.47, so iBio, Inc.'s price volatility has been higher than the market average.

Beta (5Y) 1.47
52-Week Price Change -27.31%
50-Day Moving Average 0.95
200-Day Moving Average 1.60
Relative Strength Index (RSI) 47.69
Average Volume (20 Days) 418,479

Short Selling Information

The latest short interest is 4.03 million, so 6.27% of the outstanding shares have been sold short.

Short Interest 4.03M
Short Previous Month 3.73M
Short % of Shares Out 6.27%
Short % of Float 9.14%
Short Ratio (days to cover) 5.01

Income Statement

In the last 12 months, iBio, Inc. had revenue of $1.08 million and -$34.88 million in losses. Loss per share was -$0.27.

Revenue1.08M
Gross Profit 1.08M
Operating Income -32.53M
Pretax Income -34.88M
Net Income -34.88M
EBITDA -31.93M
EBIT -32.53M
Loss Per Share -$0.27
Full Income Statement

Balance Sheet

The company has $76.65 million in cash and $2.07 million in debt, with a net cash position of $74.59 million or $1.16 per share.

Cash & Cash Equivalents 76.65M
Total Debt 2.07M
Net Cash 74.59M
Net Cash Per Share $1.16
Equity (Book Value) 78.57M
Book Value Per Share 1.22
Working Capital 72.67M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$26.94 million and capital expenditures -$648,000, giving a free cash flow of -$27.59 million.

Operating Cash Flow -26.94M
Capital Expenditures -648,000
Depreciation & Amortization 600,000
Net Borrowing -614,000
Free Cash Flow -27.59M
FCF Per Share -$0.43
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -3,025.58%
Pretax Margin -3,244.19%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

iBio, Inc. does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -496.26%
Shareholder Yield -496.26%
Earnings Yield -34.28%
FCF Yield -57.35%

Analyst Forecast

The average price target for iBio, Inc. is $5.69, which is 619.76% higher than the current price. The consensus rating is "Strong Buy".

Price Target $5.69
Price Target Difference 619.76%
Analyst Consensus Strong Buy
Analyst Count 9
Revenue Growth Forecast (3Y) 30.06%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on November 29, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date Nov 29, 2023
Split Type Reverse
Split Ratio 1:20

Scores

iBio, Inc. has an Altman Z-Score of -2.36 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -2.36
Piotroski F-Score 3